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In Vivo Confocal Microscopy for Diagnosis of
Melanoma and Basal Cell Carcinoma Using
a Two-Step Method: Analysis of 710 Consecutive
Clinically Equivocal Cases
Pascale Guitera1,2, Scott W. Menzies1, Caterina Longo3, Anna M. Cesinaro4, Richard A. Scolyer2,5 and
Giovanni Pellacani3,6
We describe two algorithms to diagnose basal cell carcinomas (BCCs) and melanomas (MMs) using in vivo
reflectance confocal microscopy (RCM). A total of 710 consecutive cutaneous lesions excised to exclude
malignancy (216 MMs, 266 nevi, 119 BCCs, 67 pigmented facial macules, and 42 other skin tumors) were imaged
by RCM. RCM features were correlated with pathology diagnosis to develop diagnostic algorithms. The
diagnostic accuracy of the BCC algorithm defined on multivariate analysis of the training set (50%) and tested
on the remaining cases was 100% sensitivity, 88.5% specificity. Positive features were polarized elongated
features, telangiectasia and convoluted vessels, basaloid nodules, and epidermal shadowing corresponding to
horizontal clefting. Negative features were non-visible papillae, disarrangement of the epidermal layer, and
cerebriform nests. Multivariate discriminant analysis on the training set (excluding the BCCs) identified seven
independently significant features for MM diagnosis. The diagnostic accuracy of the MM algorithm on the test
set was 87.6% sensitivity, 70.8% specificity. The four invasive MMs that were misdiagnosed by RCM were all of
nevoid subtype. RCM is a highly accurate non-invasive technique for BCC diagnosis. Good diagnostic accuracy
was achieved also for MM diagnosis, although rare variants of melanocytic tumors may limit the strict
application of the algorithm.
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INTRODUCTION
Cutaneous skin tumors are probably the most common tumors
in mankind and represent a major public health problem,
particularly in the Western countries. More accurate clinical
diagnosis of skin tumors is likely to improve patient manage-
ment, reduce morbidity and mortality, and generate consider-
able economic benefits. Recently, dermoscopy has improved
the accuracy of the clinical diagnosis of skin tumors and has
been shown to reduce the benign/malignant ratio of excised
tumors. Nevertheless, misdiagnosis still occurs.
In vivo reflectance confocal microscopy (RCM) allows
the visualization of the upper layers of the skin at cellular
resolution. Studies investigating the role of RCM in the
clinical diagnosis of melanocytic tumors have shown that
the identification of specific RCM features can improve the
accuracy of diagnosis (Pellacani et al. 2005, 2007; Langley
et al., 2007; Guitera et al., 2009). A model for the diagnosis
of basal cell carcinoma (BCC) with RCM was described in
2004, but was based on the RCM features of an early version
of the microscope, which was not in current widespread use
(Nori et al., 2004). Another study defined a two-step method
for diagnosis, whereby at first, melanocytic lesions were
distinguished from non-melanocytic lesions, and second,
criteria were then applied to differentiate melanomas (MMs)
from nevi. The authors described RCM features of BCCs,
based on the analysis of only 26 cases. Moreover, typical
clinical cases of BCCs were not excised, and hence, the
diagnosis of each case was not confirmed pathologically
(Segura et al., 2009).
In this study, we analyzed the RCM characteristics of a large
series of melanocytic and non-melanocytic lesions from patients
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treated at two specialized skin cancer clinics, to define a model
for accurately diagnosing BCCs and MMs, and to compare it
with previously published methods of confocal diagnosis. To
the best of our knowledge, this represents the largest such series
reported to date. Moreover, we analyzed a series of consecutive
cases, which were excised because their diagnosis, from their
clinical and/or dermoscopic features, was uncertain. First, we
characterized the features of BCCs, because, based on our
confocal and pathology experience, the diagnosis of BCCs is
more straightforward than for melanocytic lesions.
RESULTS
The study population comprised 663 patients (309 females and
354 males, median age of 53 years, interquartile range 39–66,
minimum 6 and maximum 90). The RCM features were
correlated with the histopathological diagnosis of the lesions
(Table 1). The study cohort comprised the following tumors:
K 216 MMs
K 266 nevi
K 119 BCCs
K 67 benign macules of the face, comprising mostly solar
lentigines on heavily sun-damaged skin;
K 33 actinic keratoses, Bowen disease, and squamous cell
carcinomas (SCC)
K 9 dermatofibroma
The frequencies of 47 features recorded for each
diagnostic category are reported in Table 1.
I. BCC features and algorithm
A total of 35 RCM features showed significant correlation
with the diagnosis of BCC by histopathology on univariate
analysis, compared with all non-BCCs (Table 2). In all, 19
were negative features (odds ratio (OR)o1) and 26 were
positive features (OR41).
Multivariate discriminant analysis was performed for the
identification of the independently significant features distin-
guishing between BCCs and the remaining lesions on the
training set, randomly chosen as 50% of the entire series.
Eight independently significant features were found (Table 3
and Supplementary Figures S1–4 online). The accuracy of the
model having these eight coefficients on the training set was:
97.1% sensitivity (66/68 BCCs), 93.4% specificity (267/269
other lesions); then on the test set: 100% sensitivity
(52/52 BCCs), 88.5% specificity, and area under the curve
(AUC)¼0.998 (95% confidence interval (CI): 0.979–0.997).
Interestingly, 37% (3/8) of actinic keratoses and 33% (3/9) of
SCCs were deemed to be positive for the BCC algorithm in the
test set. Moreover, 11% (12/105) of MMs were also classified
as BCCs with this algorithm on the test set. MMs were more
frequently diagnosed as BCCs when they were invasive.
Positive MMs (10/12) also had obvious MM features and were
diagnosed as such with the MM method described below.
II. MM features and algorithm
A total of 35 RCM features showed significant correlation with
the MM diagnosis by histopathology on univariate analysis
(Table 4). In all, 14 were negative features (ORo1) and 19
were positive features (OR41). Interestingly, the highest OR
was for atypical cells (defined as bright nucleated cells more
than twice the keratinocytes around) found at the dermo-epi-
dermal junction (OR¼13.9) and for pagetoid cells (OR¼11).
Univariate analysis of MMs of more than 1mm thickness
compared with MMs less than 1mm showed 14 parameters
significantly correlated with thick MMs (Po0.05). Cerebri-
form nests (OR¼ 8.3) and convoluted ‘‘glomerular’’-like
vessels (OR¼7) were the most important features. Linear
telangiectasia-like horizontal vessels, also described in BCCs,
were characteristic of thick MMs. A broadened honeycomb
pattern was the characteristic of thick MMs.
Multivariate discriminant analysis, based on the training
set excluding the BCCs, identified seven independently
significant features for the diagnosis of MMs (Table 3). In
order of importance, these features were: cerebriform nests,
atypical cobblestone pattern with small nucleated cells in the
epidermis, marked cytological atypia, and pagetoid cells, and
disarranged epidermal layer with no honey comb recognized
in some areas were associated with the MM diagnosis. Large
inter-papillae spaces filled with honeycomb or cobblestone
aspect was negatively associated with MMs.
The accuracy of the MM algorithm (7 features based on
multivariate analysis above) on the training set was: 94.5%
sensitivity (104/110 MMs), 73.9% specificity (130/176 others
without BCCs). On the test set, the accuracy of the algorithm
was: 87.6% sensitivity (92/105 MMs), 70.8% specificity
(226/319 others without BCCs), AUC¼0.854 (95% CI:
0.810–0.899). Of the 13 false-negative MMs in the test set, 7
were pigmented, with 4 of these having some dermoscopy
specific features of MMs, 1 was partially pigmented and
showed dermoscopy-specific features of MMs, 2 were lightly
colored with no specific features, and 3 were amelanotic with no
specific features. Pathology review showed that three were
‘‘early-stage’’ lentigo maligna, three were classic lentigo maligna,
two were in situ MMs of superficial spreading type associated
with nevi, three were thin (o1.0mm Breslow thickness)
superficial spreading MMs (associated with nevi in two cases),
and one was a superficial spreading MM associated with nevus
(2mm Breslow thickness). Review of the pathology slides of the
four false-negative invasive MMs revealed that each was a subtle
‘‘nevoid’’ MM. Nevoid MMs are notoriously difficult to diagnose
clinically and pathologically, and the interobserver reproduci-
bility of pathological diagnosis of them is poor.
Unsurprisingly, given their pathological resemblance to
MMs, Spitz nevi were a major pitfall for the MM algorithm,
with 56% (9/16) classified as MM as previously described for
another RCM score (Pellacani et al., 2007).
III. Overall results of the BCC and MM algorithms on a
consecutive series of suspicious lesions
The overall analysis (Table 5) on the test set of the two-step
model of first diagnosing BCCs and then MMs showed that
this two-step method had:
K 89.5% sensitivity for the diagnosis of MMs (94/105) with
92 MMs classified as such, and 2 as BCCs
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K 100% sensitivity for the diagnosis of BCCs (52/52), with
all 52 BCCs classified as BCCs with the BCC algorithm,
and 18 (34.6%) were also classified as MMs by the MM
algorithm.
K 68.4% specificity for benign lesions, including actinic
keratosis classified as benign in this calculation (130/190).
K Lastly, the overall sensitivity of the method with all
epithelial malignant tumors (BCCs and SCCs) and MMs
was 91.5% (152/166).
IV. Comparison with other published RCM diagnostic scoring
systems
K RCM score–described on melanocytic lesions only
(Pellacani et al., 2007):
The RCM score assessed on our test set showed an
accuracy for the diagnosis of MMs differentiating from
other diagnosis of 77.1% sensitivity, 76.9% specificity (for a
Table 2. RCM features showing significant
correlations with the BCC diagnosis by histopathology
on univariate analysis
BCC features OR (95% CI) P-value
Junctional nest 0.01 (0.00–0.01) o0.001
Junctional thickenings 0.01 (0.00–0.10) o0.001
Edged papillae 0.02 (0.01–0.06) o0.001
Junctional clusters 0.03 (0.03–0.18) o0.001
Widespread pagetoid infiltration 0.06 (0.01–0.23) o0.001
Papillae enlarged and policyclic 0.07 (0.01–0.48) o0.001
Round pagetoid cells 0.09 (0.03–0.21) o0.001
Pagetoid cells 0.11 (0.06–0.23) o0.001
Large interpapillary space 0.16 (0.02–1.21) 0.04
Dendritic pagetoid cells 0.18 (0.09–0.38) o0.001
Dense nest 0.19 (0.09–0.42) o0.001
Non-edged papillae 0.21 (0.12–0.35) o0.001
Cell atypia 0.22 (0.13–0.35) o0.001
Nests 0.31 (0.18–0.52) o0.001
Nucleated cells within the papilla 0.34 (0.16–0.76) 0.01
Dishomogenous nest 0.38 (0.18–0.76) 0.01
Plump bright cells 0.48 (0.32–0.72) o0.001
Atypia marked 0.52 (0.31–0.89) 0.02
Atypical HC 1.8 (1.2–2.7) 0.009
Broadened HC 2.4 (1.5–3.9) 0.001
Regular HC 4.9 (2.6–9.2) o0.001
Convoluted glomerular-like vessel 7.75 (4.76–12.6) o0.001
Non-visible papillae 28.2 (17.1–46.7) o0.001
Dendritic-like features within tumor islands 40.5 (13.8–119) o0.001
Linear telangiectasia-like horizontal vessels 41.4 (24.4–70.3) o0.001
Fibrillar polarized pattern around tumor 44.6 (21.0–94.5) o0.001
Edged papillae: absent 48.4 (17.6–133) o0.001
Epidermal shadow 62.4 (35.1–111) o0.001
Horizontal vessel 71.4 (37.9–135) o0.001
Clefting 77.8 (35.5–170) o0.001
Basaloid cord or nodules 90.1 (43.6–186) o0.001
Nucleated cell within tumor islands 92.6 (35.8–240) o0.001
Vessels: visible 114 (35.8–365) o0.001
Polarized in the HC 154 (77.6–304) o0.001
Abbreviations: BCC, basal cell carcinoma; CI, confidence interval;
HC, honeycomb; OR, odds ratio; RCM, reflectance confocal microscopy.
The cells highlighted in italics correspond to the features already
described in BCCs (Gonzalez and Tannous, 2002; Nori et al., 2004;
Agero et al., 2006; Ulrich et al., 2011), and the ones highlighted in bold
correspond to the features already described in MMs (Langley et al., 2001,
2007; Gerger et al., 2005; Pellacani et al., 2007). For definition and
reference of the features see Table 1.
Table 3. Discriminant analysis based on 50% cases
(training set): eight independent features
distinguishing between BCCs and the remaining
lesions, and on MMs compared with all other lesions
except BCCs
Coefficient
BCC features
Polarized in the HC (Supplementary Figures S3
and S4 online)
1.813
Linear telangiectasia-like horizontal vessels
(Supplementary Figure S3 online)
1.339
Basaloid cord or nodule (Supplementary
Figure S1 online)
1.288
Epidermal shadow (Supplementary Figure S4 online) 0.754
Convoluted glomerular-like vessels 0.639
Non-visible papillae 0.605
Cerebriform nests 1.230
Disarray of the epidermal layer 0.322
Constant 1.020
MM features
Cerebriform nests 1.584
Atypical cobblestone with small nucleated cells 1.485
Marked cytologic atypia 1.110
Pageoid Cells 1.091
Epidermal disarray 0.950
Large interpapillary space (Supplementary
Figure S5 online)
1.016
Dense nest 0.451
Constant 1.058
Abbreviations: BCC, basal cell carcinoma; HC, honeycomb; MM,
melanoma.
Unstandardized canonical discriminant function coefficients.
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score 43, determined to be the best threshold for melano-
cytic lesions).
The RCM score on the test set for a score 42 showed an
accuracy for the diagnosis of MMs of 88.6% sensitivity,
62.2% specificity, AUC¼ 0.828 (95% CI: 0.780–0.876).
Only 8% of BCC had an RCM score X3.
K Two-step method of Segura et al. (2009):
The two-step method described by Segura et al. (2009)
used on the test set showed an accuracy for the diagnosis
of MMs (calculated with a threshold of zero) and BCCs:
K MMs (differentiating from any other diagnosis): 76.5%
sensitivity (80/105, with 72 classified as MMs and 8 as
BCCs)
K BCCs (differentiating from any other diagnosis): 88.5%
sensitivity (46/52 with 43 classified as BCCs and 3 as
MMs)
K A totral of 9 out of 17 actinic keratosis and SCCs were
classified as MMs (n¼ 6) and BCCs (n¼3)
K The specificity for benign lesions classified as such was
72.5% (132/182)
The AUC calculated only on the subset of melanocytic
lesions of the test set (to be comparable between the
three methods) was highest for the method reported here,
although the differences were not statistically significant; to
our knowledge, the previously unreported model described
in this article obtained an AUC¼0.848 (0.799–0.897), the
algorithm by Segura et al. (2009) had an AUC¼0.804
(0.748–0.859) and the RCM score had an AUC¼0.783
(0.726–0.841).
V. Description of benign skin lesions
Table 1 reports the frequency of various RCM features of
benign skin lesions. We will comment only on different types
of nevi, excluding Spitz nevi, as their features have already
been reported (Pellacani et al., 2009).
Most of the RCM features correlate well with the well-
known pathological characteristics of melanocytic nevi. For
example, compact nests in the dermis are a typical feature of
compound and intradermal nevi, and junctional nests are
mostly seen in junctional nevi. The two main features of nevi
in the epidermis are the regular honeycomb pattern (more
than 50% of the nevi, and in particular, more than 80% of
dermal and blue nevi) and the regular cobblestone pattern
(more than 50% of nevi, with only18% of dermal nevi having
this pattern). Disarranged epidermis is more frequently seen
in junctional nevi (16%) than in other types of nevi (o10%).
Interestingly, pagetoid cells were frequently seen in this
suspicious population of junctional and compound nevi
(around 20%), but not in blue and dermal nevi. Of note, the
pagetoid spread was rarely widespread or composed of small
round cells. At the dermo-epidermal junction, edged papillae
(corresponding to regular papillae with clearly outlined
contours) were seen in more than 73% of the nevi. Atypia
of the cells was found at the dermo-epidermal junction in
Table 4. RCM features showing significant
correlations with the MM diagnosis by histopathology
on univariate analysis
RCM features OR (95% CI) P-value
Basaloid cord or nodule 0.10 (0.04–0.28) o0.001
Nucleated cell within tumor islands 0.11 (0.04–0.37) o0.001
Large interpapillary space 0.16 (0.04–0.66) 0.004
Clefting 0.16 (0.06–0.40) o0.001
Epidermal shadow 0.17 (0.09–0.35) o0.001
Fibrillar polarized pattern around tumor 0.20 (0.08–0.50) o0.001
Polarized in the HC 0.21 (0.12–0.38) o0.001
Dendritic-like features within tumor 0.25 (0.07–0.82) 0.013
Non-visible papillae 0.31 (0.19–0.50) o0.001
Linear telangiectasia-like horizontal vessel 0.36 (0.22–0.57) o0.001
Horizontal vessel 0.44 (0.29–0.68) o0.001
Dense nest 0.45 (0.29–0.70) o0.001
Vessels: visible 0.56 (0.39–0.79) 0.001
Edged papillae 0.57 (0.41–0.79) 0.001
Atypical HC 1.4 (1.0–2.1) 0.04
Junctional nest 1.5 (1.1–2.1) 0.015
Edged papillae: absent 1.8 (1.3–2.4) 0.001
Polycyclic papillae 2.4 (1.3–4.6) 0.005
Dishomogenous nest 3.0 (2.0–4.6) o0.001
HC atypical and disarray 4.2 (3.0–6.0) o0.001
Nucleated cells within the papilla 4.3 (2.8–6.7) o0.001
Atypical cobblestone pattern 4.8 (2.9–8.1) o0.001
Epidermal disarray 5.1 (3.6–7.2) o0.001
Sheet of cells 5.2 (2.3–11.8) o0.001
Atypical cobblestone with small
nucleated cells
6.0 (3.0–12.1) o0.001
Pagetoid cells localised around follicular
opening
6.3 (3.1–13.0) o0.001
Dendritic pagetoid cells 6.7 (4.6–9.7) o0.001
Non-edged papillae 7.6 (5.3–11.0) o0.001
Widespread pagetoid infiltration 7.8 (5.1–11.8) o0.001
Atypia marked 8.7 (5.9–12.8) o0.001
Round pagetoid cells 9.7 (6.7–14.1) o0.001
Pagetoid cells 11.0 (7.5–16.0) o0.001
Cell atypia 13.9 (9.2–20.9) o0.001
Abbreviations: BCC, basal cell carcinoma; CI, confidence interval; HC,
honeycomb; MM, melanoma; OR, odds ratio; RCM, reflectance confocal
microscopy.
The cells highlighted in italics correspond to the features already
described in BCCs (Gonzalez and Tannous, 2002; Nori et al., 2004;
Agero et al., 2006; Ulrich et al., 2011), and the ones highlighted in bold
correspond to the features already described in MMs (Langley et al., 2001,
2007; Gerger et al., 2005; Pellacani et al., 2007). For definition and
reference of the features see Table 1.
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approximately 30% of junctional or compound nevi, but was
not observed in dermal nevi (0%). These atypical cells were
rarely more than mildly atypical (o10% of nevi). Not
surprisingly, nests were a major feature of nevi, but they
were never cerebriform. Overall, vessels were visible in only
20% of nevi, but were more common in dermal nevi (36%).
They were mostly vertical.
DISCUSSION
The analysis of the cases in this study and the development of
the RCM model for clinical diagnosis are based on the real
clinical scenario faced by the dermatologist in the clinic
where melanocytic and non-melanocytic lesions are mixed
and only difficult cases are biopsied. It confirmed our
impression that BCC diagnosis is relatively accurate with
in vivo RCM (similar to pathology assessment). On the
contrary, MM diagnosis can be more difficult on a highly
selected series of cases chosen for their suspicious criteria by
internationally recognized dermoscopy experts. Of note, the
vast majority of mildly atypical nevi or in non-atypical nevi
with a history of change are usually monitored in our
respective institutions with digital dermoscopy or total body
photography, and hence not recruited for this study.
Most MMs that are misdiagnosed by RCM are thin tumors,
and in some instances, the actual diagnosis may be a
question of pathology interpretation. The review of pathology
slides of the four invasive MMs that were misdiagnosed by
RCM revealed that each of the cases was a subtle nevoid MM;
and in one instance, there was some question of whether the
lesion was actually an MM or a nevus. Spitz nevi and sun-
damaged macules of the face are other good examples of the
difficulties in diagnosis commonly faced by both pathologists
and RCM experts.
On univariate analysis of BCC features, the majority of
positive features have already been described and are
highlighted in italics in Table 2 (Gonzalez and Tannous,
2002; Nori et al., 2004; Agero et al., 2006; Ulrich et al.,
2011). Not surprisingly, most of the negative features have
already been described in MMs and highlighted in bold
(Langley et al., 2001, 2007; Gerger et al., 2005; Pellacani
et al., 2007). The reverse comment is also true when applying
univariate analysis of MM features, excluding BCCs in a
second step (see italics and bold in Table 4).
The BCC method that we describe is based on eight
independently significant features (Table 3):
K Polarized elongated features in the superficial layer was
the most powerful feature (Supplementary Figure S3, 4
online). It has also been reported to be correlated with
polarized and elongated nuclei of basal cells (Nori et al.,
2004)
K Linear telangiectasia-like horizontal vessels (Supplemen-
tary Figure S3 online) were a more important feature than
convoluted glomerular-like vessels. The importance of
vascularization has been reported in nearly all publica-
tions concerning RCM features of BCCs. It is also a well-
known dermoscopy criterion (Zalaudek et al. 2010)
K Basaloid cord and nodules (Supplementary Figures S1, 2
online) have also been well described in nodular BBCs,
as well circumscribed nests of hypo-reflective cells tightly
packed in a palisading way (Agero et al., 2006; Segura
et al., 2009)
Table 5. Overall analysis on the test set combining BCC and MM models
Classified as
Neither BCC nor
MM (benign), N (%)
BCC only,
N (%)
MM only,
N (%)
BCC and
MM, N (%) Total
In situ MM 8 (14.8) 1 (1.9) 42 (77.8) 3 (5.6) 54
MM o1mm 2 (5.1) 1 (2.6) 31 (79.5) 5 (12.8) 39
MM41mm 1 (8.3) 0 (0.00) 9 (75.0) 2 (16.7) 12
Benign macule of the face 18 (58.1) 4 (12.9) 5 (16.1) 4 (12.9) 31
Junctional nevus 20 (66.7) 1 (3.3) 8 (26.7) 1 (3.3) 30
Compound nevus 69 (75.8) 3 (3.3) 17 (18.7) 2 (2.2) 91
Intradermal nevus 8 (100) 0 (0.00) 0 (0.00) 0 (0.00) 8
Blue nevus 3 (100) 0 (0.00) 0 (0.00) 0 (0.00) 3
Spitz nevus 7 (43.8) 0 (0.00) 8 (50.0) 1 (6.3) 16
BCC 0 (0.00) 34 (65.4) 0 (0.00) 18 (34.6) 52
AK 3 (37.5) 3 (37.5) 2 (25) 0 (0.00) 8
SCC 3 (33.3) 2 (22.2) 3 (33.3) 1 (11.1) 9
Dermatofibroma 2 (66.7) 1 (33.3) 0 (0.00) 0 (0.00) 3
Total 144 (40.4) 50 (14.0) 125 (35.1) 37 (10.4) 356
Abbreviations: AK, actinic keratosis; BCC, basal cell carcinoma; MM, melanoma; SCC, squamous cell carcinoma.
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K Epidermal shadow (Supplementary Figure S4 online),
defined as large featureless area with blurred border
disrupting the normal epidermis and corresponding to the
horizontal clefting (due to hyporeflective stroma, Ulrich
et al., 2011) is also a useful feature
There were three negative features useful for the diagnosis
of BCCs:
K Disarray of the honeycomb epidermal layer is more
specific of MMs (Pellacani et al., 2007), and the
honeycomb pattern was recognized in more than 90%
of the BCCs of this series
K Papillae were ‘‘non-visible,’’ meaning that BCC structures
altered the normal junction organization. Papillae (corre-
sponding to dark round to oval features surrounded by
epidermis in RCM sections) were disrupted in 97% of the
119 BCCs of our series
K Lastly, cerebriform nests are rare, but very specific of
nodular MMs (Pellacani et al., 2007; Segura et al.,
2008). They were not recorded in our series of 119
BCCs. They were also not recorded in benign melano-
cytic lesions
MMs (10/12) diagnosed as BCCs by the BCC algorithm
also contained obvious MM features, and were diagnosed as
such with the MM method described as a second step. It
seems that basaloid cords and nodules are highly specific of
BCCs. They were found only in few thick MMs, where MM
nests simulated BCC islands, but in context, it was often easy
to detect specific MM features.
One third of the actinic keratosis and SCC lesions were
diagnosed as BCCs, and they were the main pitfall of this
BCC method. As actinic keratoses are an important differ-
ential diagnosis of BCCs, this RCM finding could lead to
unnecessary biopsies of actinic keratoses. It should be noted
that actinic keratosis and SCCs have a relatively small sample
size in our study; hence, it would be poorly modeled
compared with high prevalent lesions. These lesions are often
covered by a thick keratin layer that is highly reflective, so the
images under this layer are blurred and not readable with
RCM. Therefore, the subset of actinic keratoses imaged was
pre-selected. Moreover, our consecutive cases included only
a limited number of non-melanocytic tumors that would be
appropriately considered in the differential diagnosis of BCCs
and MMs, such as atypical seborrheic keratoses (n¼ 8,
pooled in the differential diagnosis of lentigo maligna),
atypical dermatofibromas (n¼9), sebaceous hyperplasia
(n¼0), and pyogenic granulomas (n¼0). These subsets will
need to be studied in a larger series.
In conclusion, to our knowledge, we are reporting a
previously unreported two-step RCM method for the diag-
nosis of skin tumors based on a large series of melanocytic
and non-melanocytic lesions, and demonstrate that RCM is a
valuable non-invasive tool to diagnose skin tumors. It can be
used, in particular, to obtain a non-invasive quasi-histological
diagnosis for BCCs and to follow efficiency of treatments. It
has also been proposed as a method for determining tumor
margins in vivo, but its efficacy for this purpose has not been
proven. Particular features of different subtypes of BCCs have
not been addressed in our series, and more research should
be directed to confirm if RCM is a particularly valuable tool
on difficult subtypes of BCCs, such as infiltrative ones. RCM is
also a very valuable tool for the diagnosis of MMs. RCM is not
replacing dermoscopy as it is not a screening tool, because
diagnosis of one lesion requires at least 5minutes. Never-
theless, RCM evaluation can dramatically reduce (by 68% in
this series) the unnecessary excisions of benign lesions even
in expert institutions. As previously reported (Guitera et al.,
2009), we have shown that dermoscopy and RCM are
relatively poorly correlated for the diagnosis of atypical
melanocytic lesions. In this regard, although RCM and
dermoscopy have the same sensitivity for the diagnosis of
MMs (91%, 95% CI: 84.6–95.5 for RCM, and 88%, 95% CI:
80.7–92.6 for dermoscopy), the sensitivity increases drama-
tically to 98% when lesions are excised, because of either the
RCM or dermoscopy evidence of MMs.
Improved accuracy of the clinical diagnosis of skin tumors
would be of great public health benefit.
MATERIALS AND METHODS
Lesion recruitment was performed in two secondary care settings:
the Sydney Melanoma Diagnostic Centre, Australia, and the
Department of Dermatology, University of Modena, Italy. Con-
secutive patients, presenting or found with suspicious lesions,
including all macules of the face and neck, suspicious for lentigo
maligna, and which would be subjected to biopsy or excision to rule
out an epithelial tumor or an MM, following conventional clinical
and dermoscopy diagnosis, were entered into the study. The location
had to be amenable to examination by RCM, as an adhesive ring of
2 cm must be used, precluding the inclusion of lesions behind the
ear, some parts of the edge of the nose or eyes. Because RCM
penetration is only 0.2mm beneath the skin surface, keratotic, sole,
and palms lesions were excluded. Therefore, the cases consisted
predominantly of BCCs and melanocytic tumors; there were
insufficient numbers of SCCs and actinic keratoses to allow
development of accurate RCM diagnosis of the latter tumors.
Therefore, 19 actinic keratosis, 12 Bowen’s disease, and 2 SCCs
have been pooled together. The recruitment criteria were the same
in the two centers. This study was approved by the Ethics
Committees in Sydney (protocol number X05-0218) and in Modena
(protocol number 1338/CE), and signed consent was obtained. All
clinical investigations were conducted according to the Declaration
of Helsinki Principles.
Instruments and acquisition procedures have been similar to ones
described in the article (Guitera et al., 2009).
Confocal diagnosis
RCM features were described by two expert observers (GP and PG),
blinded from any clinical information, dermoscopy, and clinical
aspects, but not for the location and age of the patient. In detail, each
observer evaluated the images previously randomized between the
two centers, opening codified folders containing all the images
acquired for the corresponding case. At the end of the study, the
patients’ codes were broken and the evaluations were matched with
pathology before statistical analysis.
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A series of 48 features, corresponding to previous observations
(Pellacani et al., 2007; Guitera et al., 2009), and new descriptors
were considered at three different depth levels. Description and
definitions are summarized in Table 1. All these features were
evaluated for their presence/absence (binary non-parametric
data).
Statistics
Statistical evaluation was carried out employing the SPSS statistical
package (release 12.0. 0, 2003; SPSS, Chicago, Ill., USA).
Absolute and relative frequencies of the observations in benign
and malignant lesions were obtained for each RCM feature. By
univariate analysis, we compared BCCs with all other lesions, MMs
with all other lesions, and thin MMs (o1mm) with thick MMs
(41mm). Significant differences were evaluated by means of the
w2-test of independence (Fisher’s exact test was applied if any
expected cell value in the 2 2 table was less than 5). For an estimate
of risk, a calculation of the OR and 95% CI was carried out.
Multivariate discriminant analysis was performed for the identi-
fication of the independently significant features, and for the
validation of the efficacy of RCM in distinguishing between BCCs
and the rest of the lesions, and then MMs (excluding BCCs) and the
rest of the lesions on the training set, randomly chosen as 50% of our
series. A coefficient is estimated for each included variable in
relation to the likeliness to predict a BCC, and then an MM lesion.
The algorithm was then used on the test set constituted by the
remaining 50% of the population.
Receiver operating characteristic analysis was performed to
investigate sensitivity and specificity of the discriminant analysis
equations for the BCC, and then the MM algorithms (McNeil and
Hanley, 1984). The AUC, which represents an index of the overall
discriminant power, was calculated by the non-parametric trape-
zoidal method. The model, along with its parameter estimates, was
then used for prediction and estimation of the AUC in the test set.
Sensitivity, specificity, diagnostic accuracy, OR, and 95% CI, were
calculated for each score value. A P-value o0.05 was considered
significant.
Pathology review
The lesions of the test set found to be false negatives with the MM
model, and a subset of false positives (those available and all
Spitzoid lesions) were reviewed.
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